These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 26299230

  • 21. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
    Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
    [Abstract] [Full Text] [Related]

  • 22. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.
    Ghali JK, Anand IS, Abraham WT, Fonarow GC, Greenberg B, Krum H, Massie BM, Wasserman SM, Trotman ML, Sun Y, Knusel B, Armstrong P, Study of Anemia in Heart Failure Trial (STAMINA-HeFT) Group.
    Circulation; 2008 Jan 29; 117(4):526-35. PubMed ID: 18195176
    [Abstract] [Full Text] [Related]

  • 23. Long-term retinal, renal and cardiovascular outcomes in diabetic chronic kidney disease without proteinuria.
    Agarwal R, Debella YT, Giduma HD, Light RP.
    Nephrol Dial Transplant; 2012 Jan 29; 27(1):310-7. PubMed ID: 21669884
    [Abstract] [Full Text] [Related]

  • 24. Kidney Function and Cardiovascular Events in Postmenopausal Women: The Impact of Race and Ethnicity in the Women's Health Initiative.
    Arce CM, Rhee JJ, Cheung KL, Hedlin H, Kapphahn K, Franceschini N, Kalil RS, Martin LW, Qi L, Shara NM, Desai M, Stefanick ML, Winkelmayer WC, Women’s Health Initiative Investigators.
    Am J Kidney Dis; 2016 Feb 29; 67(2):198-208. PubMed ID: 26337132
    [Abstract] [Full Text] [Related]

  • 25. Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked National Cardiovascular Data Registry and centers for Medicare & Medicaid services payer databases.
    Kumar RS, Douglas PS, Peterson ED, Anstrom KJ, Dai D, Brennan JM, Hui PY, Booth ME, Messenger JC, Shaw RE.
    Circulation; 2013 Apr 02; 127(13):1395-403. PubMed ID: 23547179
    [Abstract] [Full Text] [Related]

  • 26. Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: results from the 1997 ESRD Core Indicators Project.
    Frankenfield DL, Rocco MV, Frederick PR, Pugh J, McClellan WM, Owen WF.
    Am J Kidney Dis; 1999 Oct 02; 34(4):721-30. PubMed ID: 10516355
    [Abstract] [Full Text] [Related]

  • 27. Racial differences in long-term survival among patients with coronary artery disease.
    Thomas KL, Honeycutt E, Shaw LK, Peterson ED.
    Am Heart J; 2010 Oct 02; 160(4):744-51. PubMed ID: 20934570
    [Abstract] [Full Text] [Related]

  • 28. Treatment of anemia with darbepoetin alfa in heart failure.
    Abraham WT, Anand IS, Klapholz M, Ponikowski P, Scarlata D, Wasserman SM, van Veldhuisen DJ.
    Congest Heart Fail; 2010 Oct 02; 16(3):87-95. PubMed ID: 20557327
    [Abstract] [Full Text] [Related]

  • 29. Outcomes for adolescent Hispanic hemodialysis patients: findings from the ESRD Clinical Performance Measures Project.
    Frankenfield DL, Atkinson MA, Fivush BA, Neu AM.
    Am J Kidney Dis; 2006 May 02; 47(5):870-8. PubMed ID: 16632027
    [Abstract] [Full Text] [Related]

  • 30. Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients.
    Minutolo R, Conte G, Cianciaruso B, Bellizzi V, Camocardi A, De Paola L, De Nicola L.
    Nephrol Dial Transplant; 2012 Jul 02; 27(7):2880-6. PubMed ID: 22319218
    [Abstract] [Full Text] [Related]

  • 31. Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction.
    Newsome BB, McClellan WM, Allison JJ, Eggers PW, Chen SC, Collins AJ, Kiefe CI, Coffey CS, Warnock DG.
    Am J Kidney Dis; 2008 Aug 02; 52(2):251-61. PubMed ID: 18468746
    [Abstract] [Full Text] [Related]

  • 32. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM, Kirchner HL, Hartle JE, Bucaloiu ID.
    Clin Nephrol; 2013 Oct 02; 80(4):256-62. PubMed ID: 23993165
    [Abstract] [Full Text] [Related]

  • 33. Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus.
    Barbhaiya M, Feldman CH, Guan H, Gómez-Puerta JA, Fischer MA, Solomon DH, Everett B, Costenbader KH.
    Arthritis Rheumatol; 2017 Sep 02; 69(9):1823-1831. PubMed ID: 28598016
    [Abstract] [Full Text] [Related]

  • 34. Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    O'Neal WT, Tanner RM, Efird JT, Baber U, Alonso A, Howard VJ, Howard G, Muntner P, Soliman EZ.
    Int J Cardiol; 2015 Apr 15; 185():219-23. PubMed ID: 25797681
    [Abstract] [Full Text] [Related]

  • 35. Revisiting racial differences in ESRD due to ADPKD in the United States.
    Murphy EL, Dai F, Blount KL, Droher ML, Liberti L, Crews DC, Dahl NK.
    BMC Nephrol; 2019 Feb 14; 20(1):55. PubMed ID: 30764782
    [Abstract] [Full Text] [Related]

  • 36. Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease.
    Bello NA, Lewis EF, Desai AS, Anand IS, Krum H, McMurray JJ, Olson K, Solomon SD, Swedberg K, van Veldhuisen DJ, Young JB, Pfeffer MA.
    Eur J Heart Fail; 2015 Nov 14; 17(11):1201-7. PubMed ID: 26423928
    [Abstract] [Full Text] [Related]

  • 37. Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system.
    Derose SF, Rutkowski MP, Crooks PW, Shi JM, Wang JQ, Kalantar-Zadeh K, Kovesdy CP, Levin NW, Jacobsen SJ.
    Am J Kidney Dis; 2013 Aug 14; 62(2):236-44. PubMed ID: 23499049
    [Abstract] [Full Text] [Related]

  • 38. Race/ethnic disparities in risk factor control and survival in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial.
    Beohar N, Sansing VV, Davis AM, Srinivas VS, Helmy T, Althouse AD, Thomas SB, Brooks MM, BARI 2D Study Group.
    Am J Cardiol; 2013 Nov 01; 112(9):1298-305. PubMed ID: 23910429
    [Abstract] [Full Text] [Related]

  • 39. Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies.
    Minutolo R, Gabbai FB, Provenzano M, Chiodini P, Borrelli S, Garofalo C, Sasso FC, Santoro D, Bellizzi V, Conte G, De Nicola L.
    Nephrol Dial Transplant; 2018 Nov 01; 33(11):1942-1949. PubMed ID: 29509925
    [Abstract] [Full Text] [Related]

  • 40. Racial disparities in end-stage renal disease in a high-risk population: the Southern Community Cohort Study.
    Bock F, Stewart TG, Robinson-Cohen C, Morse J, Kabagambe EK, Cavanaugh KL, Birdwell KA, Hung AM, Abdel-Kader K, Siew ED, Akwo EA, Blot WJ, Ikizler TA, Lipworth L.
    BMC Nephrol; 2019 Aug 07; 20(1):308. PubMed ID: 31390993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.